Biofrontera
BFRI
12 hedge funds and large institutions have $1.94M invested in Biofrontera in 2026 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 1 reducing their positions, and 3 closing their positions.
600% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 1
45% more capital invested
Capital invested by funds: $1.33M → $1.94M (+$603K)
0.47% more ownership
Funds ownership: 20.07% → 20.54% (+0.47%)
14% less funds holding
Funds holding: 14 → 12 (-2)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$37.5K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$23.3K |
| 3 |
RA
Rosalind Advisors
Toronto,
Ontario, Canada
|
+$20K |
| 4 |
Citigroup
New York
|
+$10.2K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$3.12K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$18.7K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$7.68K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$7.6K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$47 |
BFRI Hedge Fund Activity: Q1 2026 in Review
12 of the 8,206 institutional investors tracked by Wall St. Rank reported a position in Biofrontera (BFRI) for Q1 2026, worth a combined $1.94M — up 45% from $1.33M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of BFRI and 2 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 7 added.
The largest buyer was Geode Capital Management, adding an estimated $37.5K. The largest seller was Jane Street, exiting entirely with an estimated $18.7K sold.
- 12 institutional investors held Biofrontera (BFRI) as of Q1 2026, down from 14 in Q4 2025.
- Funds reported $1.94M of Biofrontera stock for Q1 2026, up 45% quarter-over-quarter.
- 2 funds opened new Biofrontera positions in Q1 2026 and 3 closed out, a net change of -1 holder.
- The largest Biofrontera buyer in Q1 2026 was Geode Capital Management, an estimated $37.5K added.
- The largest Biofrontera seller in Q1 2026 was Jane Street, an estimated $18.7K sold.
Based on aggregated 13F filings for Q1 2026.